IP Library › Granted Patent US 9,510,780
Granted Patent B2
US 9,510,780 · App. 14/701,390 · Granted Dec 6, 2016

Sensors for detecting substances in bodily fluids

Inventor: James H. Silver (Palo Alto, CA)
A61B5/14546A61B5/0031A61B5/0205A61B5/1477A61B5/14532A61B5/14557A61B5/14865A61B5/4076A61B5/413A61B5/686A61B5/6862A61B5/6876A61B5/6882G01N33/84A61B5/0215A61B5/1459A61B5/14528A61B5/14539A61B5/14735A61B5/412A61B5/4839A61B2560/0219A61B2562/0209A61F2/82A61F2250/0001Y10T436/177692
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,510,780
App. No.
14/701,390
Granted
Dec 6, 2016
Kind
B2
Abstract

A system is disclosed that extracts bodily fluid to a reaction chamber for monitoring a substance or property of the patient fluid. In one embodiment, a pump is used to advance the sample of bodily fluid through a filter to produce a filtrate. Another pump advances filtrate into the reaction chamber, while another pump advances reactant into the reaction chamber. A sensor in communication with the reaction chamber determines a concentration of nitric oxide or one of its metabolic products. Methods are also disclosed.

Claims (21)

1. An apparatus for measuring nitrite in blood of a human or animal subject, the apparatus comprising:

a housing, at least a portion of which is configured to contact the blood of the subject;

a size-exclusion filter within the housing, configured to allow nitrite ions to pass through the filter and impede passage of particles having a molecular weight greater than about 60 kD through the filter;

a nitrite reduction agent within the housing, configured to reduce nitrite ions to nitric oxide; and

a nitric oxide electrode within the housing for measuring nitric oxide.

2. The apparatus of claim 1 , wherein the housing comprises a needle configured for advancement into a blood vessel of the subject.

3. The apparatus of claim 1 , wherein the filter is configured to exclude hemoglobin and erythrocytes.

4. The apparatus of claim 1 , further comprising a vacuum source coupled with the housing, configured to improve flux through the filter.

5. The apparatus of claim 1 , wherein the filter comprises a membrane comprising a material selected from the group consisting of polycarbonate, polysulfone, polyethersulfone, polyarylethersulfone, polyurethane, polyacrylonitrile, regenerated cellulose, mixed cellulose ester, polyester, Nylon, poly(vinylidene fluoride) (PVDF), polypropylene, and polytetrafluoroethylene.

6. The apparatus of claim 1 , wherein the filter comprises a thromboresistant coating.

7. The apparatus of claim 1 , wherein the nitrite reduction agent comprises a constant voltage electrode.

8. The apparatus of claim 7 , further comprising a constant voltage source configured to be coupled to the constant voltage electrode.

9. The apparatus of claim 8 , wherein the constant voltage source and the constant voltage electrode are configured to apply a voltage of about 1.2 V referenced to a normal hydrogen electrode (NHE).

10. The apparatus of claim 1 , wherein the nitrite reduction agent comprises:

an anion-exchange membrane within the size-exclusion filter, configured to allow nitrite ions to pass through the membrane and impede passage of cations; and

a dilute acid within the anion-exchange membrane.

11. The apparatus of claim 10 , wherein the dilute acid comprises less than about 1 ml of a dilute acid.

12. The apparatus of claim 10 , wherein the dilute acid comprises carbonic acid.

13. The apparatus of claim 10 , further comprising:

an anode positioned between the size-exclusion filter and the anion-exchange membrane; and

a cathode positioned within the anion-exchange membrane, wherein the anode and cathode are in electrical communication with a voltage source.

Continuity (5)
Division 13804184 · Mar 14, 2013
Continuation 13359313 · Jan 26, 2012
Continuation 12015347 · Jan 16, 2008
Continuation In Part 11280680 · Nov 16, 2005
Related Publication 20150230742A1 · Aug 20, 2015